SB-300, Jaguar's Drug Product Candidate for the Treatment of Gastric Ulcers, Enables Continued Therapy in Performance Horses in Accordance with Standard Testing Guidelines

Results of Initial Study Show that Jaguar's Equine Product Candidate for Treatment of Gastric Ulcers May Offer Horse Owners an Additional Advantage in the Competition Horse World, where Requirements Exist for Animals to Compete Free from the Effect of Any Drugs

Read It Now

Sign Up for our Free eNews

Sunday

September 24, 2017

Sorry, no events.

Monday

September 25, 2017

Sorry, no events.

Tuesday

September 26, 2017

Sorry, no events.

Wednesday

September 27, 2017

Sorry, no events.

Thursday

September 28, 2017

Sorry, no events.

Friday

September 29, 2017

Sorry, no events.

Saturday

September 30, 2017